Furthermore, research indicates that NRF2 deficiency contributes to the development of insulin resistance in the liver in the context of MASLD, while NRF2 activation enhances insulin sensitivity (Liu et al., 2016; Yu et al., 2019), highlighting its significant protective effect against liver diseases. This evidence concerns the gene NFE2L2 and liver disorder.